Dear Colleagues,

We hope you enjoyed Euroleuk2022.
Details & dates for Euroleuk2023 Coming Soon!

It is with great pleasure that we invite you to join us in person at The 3rd European Congress on Controversies in Leukemias (Euroleuk2022) which will take place 2-3 November 2022 in Copenhagen, Denmark.

Euroleuk2022 will continue to provide clinicians and biologists with state-of-the-art recommendations regarding patient care and insights into controversies and new therapeutic perspectives in the field.

 

Alessandro Isidori, MD, PhD,
Hematology and Stem Cell Transplant Center
Marche Nord Hospital – Pesaro – Italy
Congress Chair

READ MORE

SCIENTIFIC PROGRAM

Click Here

REGISTRATION

Click Here

SPONSORSHIP OPPORTUNITIES

Click Here

GENERAL INFORMATION

Click Here

SPONSORS

PLATINUM SPONSOR
 READ MORE
SPONSOR
 READ MORE
SPONSOR
 READ MORE
All Sponsors

Scientific Program

08:00
Registration
09:00
The Role of Metabolism in The Development of Personalized Therapies in Acute Myeloid Leukemia (AML)
Paolo Gallipoli

Center or Haemato-Oncology, Barts Cancer Institute, UK
09:30
NOTCH in Chronic Lmphocytic Leukemia (CLL) and hematological cancers: a daunting story
Paolo Sportoletti

Hematology Section, University of Perugia, Italy
10:00
Targeting microenvinroment in leukemias
Antonio Curti

St. Orsola - Malpighi Polyclinic, Bologna University, Italy
11:00
European LeukemiaNet (ELN) and International Consensus Classification (ICC)
Jorge Sierra

Hospital de la Santa Creu i Sant Pau, Spain
11:20
World Health Organisation (WHO)
Klaus Metzeler

University of Leipzig, Germany
11:40
Debate
Jorge Sierra

Hospital de la Santa Creu i Sant Pau, Spain
Klaus Metzeler

University of Leipzig, Germany
Alessandro Isidori - Congress Chair

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy
12:00
New Insights into the biology of NPM-1 mutated Acute Myeloid Leukemia (AML)
Lorenzo Brunetti

Università Politecnica delle Marche, Italy
13:30
Minimal residual disease: how does it guide our treatment choices?
Francesco Buccisano

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Italy
14:00
Clinical and molecular fitness (pre-recorded)
Felicetto Ferrara

Hematology Division, A. Cardarelli Hospital, Naples, Italy
14:30
Front-line treatment for newly diagnosed Acute Myeloid Leukemia (AML)
Giuseppe Visani
Hematology and Stem Cell Transplant Center, AORMN Hospital, Italy
15:30
How I manage high-risk Acute Myeloid Leukemia (AML)
Thomas Cluzeau

Centre Hospitalier Universitaire de Nice (CHU de Nice), France
Show Summary
16:00
Maintenance therapy
Klaus Metzeler

University of Leipzig, Germany
16:30
FLT3 positive Acute Myeloid Leukemia (AML)
Alessandro Isidori - Congress Chair

Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Italy
17:00
Targeting IDH1 and IDH 2 in Acute Myeloid Leukemia (AML)
Adolfo de la Fuente Burguera

MD Anderson Cancer Center Madrid, Spain
17:30
Treatment of resistant-refractory disease
Yngvar Floisand

 Arog Pharmaceuticals and DAVA Oncology, and researcher at CanCell University of Oslo, Norway
08:00
Registration
09:00
How I manage large granular cell leukemia
Renato Zambello

Hematology at the Department of Medicine, University of Padova, Italy
09:30
Front-line treatment in Chronic Lymphocytic Leukemia (CLL)
Talha Munir
St. James’s University Hospital, Leeds, UK
09:50
Practical management of Chronic Lymphocytic Leukemia (CLL) patients treated with novel agents
Lydia Scarfò

Department of Onco-Hematology, San Raffaele Scientific Institute, Italy
10:10
Management of Chronic Lymphocytic Leukemia (CLL) in countries with low-income economy
Jean El-Cheikh

American University of Beirut Medical Center, Lebanon
11:00
Allo-SCT 3.0 in the Elderly: towards new eligibility criteria and tailored conditioning platforms
Michele Malagola

Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, Italy
11:30
New insights on immune reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): microbiome and Cytomegalovirus (CMV) specific responses
Raffaela Greco

IRCCS San Raffaele Hospital, Milano, Italy
12:00
Maintenance therapy post allogeneic transplant in Acute Myeloid Leukemia (AML)
Jean El-Cheikh

American University of Beirut Medical Center, Lebanon
13:30
Philadelphia positive Acute Myeloid Leukemia (ALL)
Oliver Ottmann
Haematology Division of Cancer and Genetics, Cardiff University, UK
14:00
Monoclonal antibodies: the gamechangers in Acute lymphoblastic leukema (pre-recorded)
Claudio Cerchione

Hematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Italy
14:30
How I treat Chronic Myeloid Leukemia (CML) in 2022
Giuseppe Saglio
Hematology & Internal Medicine, University of Turin, Italy

Contact Us

Please drop us a line with any questions or comments you may have.

We look forward to hearing from you.